GI Surgery – Biliary Tract and Pancreas
Systematic Review: Duct‐to‐mucosa vs. other types of pancreaticojejunostomy for the prevention of postoperative pancreatic fistula following pancreaticoduodenectomy.
24 Mar, 2022 | 08:27h | UTC
Evidence-based disposition of acute pancreatitis.
22 Mar, 2022 | 08:08h | UTCEvidence-Based Disposition of Acute Pancreatitis – emDocs
Related Guidelines:
Pancreatitis – National Institute for Health and Care Excellence
Diagnostic approach to incidentally detected pancreatic cystic lesions.
18 Mar, 2022 | 08:11h | UTCRelated:
Cystic pancreatic lesions: MR imaging findings and management.
Recommendations for the management of incidental pancreatic findings in adults.
Pancreatic cystic neoplasms: a review of current recommendations for surveillance and management
Management of Pancreatic Cystic Lesions
Consensus Recommendations: Diagnosis and Surveillance of Incidental Pancreatic Cystic Lesions
Review: Pancreatic Cystic Lesions
Guidelines on pancreatic cystic neoplasms
RCT: Effect of early vs. late supplemental parenteral nutrition in patients undergoing abdominal surgery.
17 Mar, 2022 | 08:43h | UTCInvited Commentary: Early Postoperative Supplementary Parenteral Nutrition – JAMA Surgery
Author Interview: Supplemental Parenteral Nutrition in Patients Undergoing Abdominal Surgery
Commentary on Twitter
Randomized clinical trial found supplemental parenteral nutrition in combination with enteral nutrition could significantly reduce the incidence of nosocomial infections in patients undergoing abdominal surgery. https://t.co/Agbf9TKPfX
— JAMA Surgery (@JAMASurgery) March 16, 2022
Review: Acute cholecystitis.
11 Mar, 2022 | 09:40h | UTCAcute Cholecystitis: A Review – JAMA (free for a limited period)
Author Interview: Acute Cholecystitis
RCT: Preliminary trial suggests neostigmine may improve intra-abdominal hypertension and increase defecation in patients with acute pancreatitis.
6 Mar, 2022 | 23:39h | UTC
Cancer risks other than female breast and ovarian cancers associated with BRCA1 and BRCA2 pathogenic variants.
3 Mar, 2022 | 08:14h | UTCCancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants – Journal of Clinical Oncology
Commentary: Faulty BRCA genes linked to prostate and pancreatic cancers – University of Cambridge
Systematic Review: Postcholecystectomy diarrhea rate and predictive factors.
2 Mar, 2022 | 08:48h | UTC
Acute pancreatitis in pregnancy: meta-analysis of maternal and fetal outcomes.
25 Feb, 2022 | 10:39h | UTC
Commentary on Twitter
Open Access in January's BJS: Acute pancreatitis in pregnancy: meta-analysis of maternal and fetal outcomes https://t.co/wB68RFQ57g @AmyLightnerMD @bplwijn @des_winter @ksoreide @MalinASund @evanscolorectal @nfmkok @robhinchliffe1 @young_bjs pic.twitter.com/eMGzExNJsM
— BJS (@BJSurgery) January 7, 2022
Current State of Imaging of Pediatric Pancreatitis: AJR Expert Panel Narrative Review.
24 Feb, 2022 | 10:13h | UTC
APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis.
15 Feb, 2022 | 09:56h | UTCRelated:
A consensus integrated care pathway for patients with primary biliary cholangitis.
Biliary Endoscopy in the Management of Primary Sclerosing Cholangitis and its Complications
M-A: Pain management in acute pancreatitis.
10 Feb, 2022 | 08:29h | UTC
Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer.
8 Feb, 2022 | 08:31h | UTCExpert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer – ESMO Open
Guideline: Management and follow-up of gallbladder polyps – “If the patient has no risk factors for malignancy, and a gallbladder polypoid lesion of 5 mm or less, follow-up is not required”.
7 Feb, 2022 | 08:39h | UTC
RCT: Early drain removal is safe in patients with low or intermediate risk of pancreatic fistula after pancreaticoduodenectomy.
1 Feb, 2022 | 08:33h | UTCEarly Drain Removal is Safe in Patients With Low or Intermediate Risk of Pancreatic Fistula After Pancreaticoduodenectomy: A Multicenter, Randomized Controlled Trial – Annals of Surgery (link to abstract – $ for full-text)
Long-Term Results of RCT: Neoadjuvant chemoradiotherapy vs. upfront surgery for resectable and borderline resectable pancreatic cancer.
28 Jan, 2022 | 08:01h | UTCNeoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial – Journal of Clinical Oncology (link to abstract – $ for full-text)
M-A: Impact of enhanced recovery protocols after pancreatoduodenectomy.
24 Jan, 2022 | 08:00h | UTCImpact of enhanced recovery protocols after pancreatoduodenectomy: meta-analysis – British Journal of Surgery (link to abstract – $ for full-text)
Related:
See also: Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines (some guidelines are free)
Commentary on Twitter
Do you apply @ErasSociety protocols 🤸♀️after pancreatoduodenectomy ?!
🌐 Meta analysis on > 3000 cases
⬇️ ERAS decreases overall morbidity, DGE, hospital stay, readmission rate
🏥 ERAS should be implemented, but in ALL patients?! https://t.co/fSmPYdof57 pic.twitter.com/L02q7bkLWU
— Giovanni Marchegiani (@Gio_Marchegiani) January 22, 2022
RCT: Pancreatoduodenectomy with or without prophylactic falciform ligament wrap around the hepatic artery for prevention of postpancreatectomy haemorrhage.
13 Jan, 2022 | 08:35h | UTCPancreatoduodenectomy with or without prophylactic falciform ligament wrap around the hepatic artery for prevention of postpancreatectomy haemorrhage: randomized clinical trial (PANDA trial) – British Journal of Surgery (link to abstract – $ for full-text)
Commentary on Twitter
In Jan's BJS: Pancreatoduodenectomy with/without prophylactic falciform ligament wrap around hepatic artery: PANDA trial https://t.co/itf6rQsxMP @AmyLightnerMD @bplwijn @des_winter @ksoreide @MalinASund @evanscolorectal @nfmkok @robhinchliffe1 @young_bjs pic.twitter.com/YpBocbplUn
— BJS (@BJSurgery) January 11, 2022
Systematic Review: Antecolic vs. retrocolic reconstruction after partial pancreaticoduodenectomy.
12 Jan, 2022 | 08:38h | UTCAntecolic versus retrocolic reconstruction after partial pancreaticoduodenectomy – Cochrane Library
Meta-analysis (mostly of observational studies): In patients undergoing pancreaticoduodenectomy, routine nasogastric decompression is associated with increased rates of delayed gastric emptying, major complications, and longer length of stay compared to no routine nasogastric decompression.
8 Jan, 2022 | 22:44h | UTCRelated Study: Nasogastric Decompression vs No Decompression After Pancreaticoduodenectomy: The Randomized Clinical IPOD Trial – JAMA Surgery
Commentary on Twitter
Nasogastric decompression after pancreaticoduodenectomy 🐘 what is your practice?!
👎 Routine NG tube associated with ⬆️ rates of DGE, major complications and longer length of stay
✅ @ErasSociety policies should be standard
New meta analys on @BjsOpen https://t.co/OStyWOfrPV pic.twitter.com/tuwjPYFWia
— Giovanni Marchegiani (@Gio_Marchegiani) January 3, 2022
M-A: Effects of immediate or early oral feeding on acute pancreatitis.
9 Dec, 2021 | 10:14h | UTC
M-A: Treatment for gastrointestinal and pancreatic neuroendocrine tumors.
26 Nov, 2021 | 09:53h | UTCSummary: Treatment options for neuroendocrine tumours – Cochrane Library
Guideline | Endoscopic tissue sampling – Part 1: Upper gastrointestinal and hepatopancreatobiliary tracts.
26 Nov, 2021 | 09:41h | UTC
Making Sense of a Complex Disease: A Practical Approach to Managing Neuroendocrine Tumors.
9 Nov, 2021 | 01:04h | UTC
Commentary on Twitter
#Neuroendocrine tumors are heterogeneous with a complex treatment landscape. This #JCOOP Clinical Review discusses optimal management of #NET and key patient/tumor characteristics that can guide treatment selection https://t.co/zZF36E93w8 pic.twitter.com/2xqwOlwIvw
— Journal of Clinical Oncology (@JCO_ASCO) October 28, 2021
Review: Clinical management of pancreatic premalignant lesions.
31 Oct, 2021 | 19:56h | UTCClinical Management of Pancreatic Premalignant Lesions – Gastroenterology